Effects on cocaine and food self-administration of (+)-HA-966, a partial agonist at the glycine/NMDA modulatory site, in rats

Psychopharmacology

Volumn 173, Issue 1, 2004, Pages 124-131

  Cervo, Luigi ^a   Cocco, Arianna ^a   Carnovali, Francesco ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

(+) HA 966; Cocaine; Food; Glycine partial agonist; Reinforcement

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; AMINO ACID RECEPTOR AFFECTING AGENT; COCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATHETERIZATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG SELF ADMINISTRATION; EVALUATION; FOOD INTAKE; MALE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; TRAINING;

ANALYSIS OF VARIANCE; ANIMALS; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; FOOD; GLYCINE; MALE; N-METHYLASPARTATE; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TIME FACTORS;

EID: 2342616085     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1703-8     Document Type: Article

References (51)

1. Arnold JM, Roberts DC (1997) A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57:441-447
2. Bormann J (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 166:591-592
3. Brebner K, Phelan R, Roberts DC (2000) Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology 148:314-321
4. Bristow LJ, Hutson PH, Thorn L, Tricklebank MD (1993) The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Br J Pharmacol 108:1156-1163
5. Caine SB, Koob GF (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav Pharmacol 6:333-347
6. Caine SB, Lintz R, Koob GF (1993) Intravenous drug self-administration techniques in animals. In: Shagal EA (ed) Behavioral neuroscience: a practical approach. Oxford University Press, Oxford, pp-117-143
7. Caine SB, Negus SS, Mello NK, Bergman J (1999) Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353-360
8. Delfs JM, Schreiber L, Kelley AE (1990) Microinjection of cocaine into die nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10:303-310
9. Everitt BJ, Wolf ME (2002) Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 22:3312-3320
10. Fagg GE, Olpe HR, Pozza MF, Baud J, Steinmann M, Schmutz M, Portet C, Baumann P, Thedinga K, Bittiger H, Allgeier H, Heckendorn R, Angst C, Brundish D, Dingwall JG (1990) CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br J Pharmacol 99:791-797
11. Glick SD, Maisonneuve IM, Dickinson HA, Kitchen BA (2001) Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats. Eur J Pharmacol 422:87-90
12. Hernandez L, Hoebel BG (1988) Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 42:1705-1712
13. Hutson PH, Bristow LJ, Thorn L, Tricklebank MD (1991) R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br J Pharmacol 103:2037-2044
14. Hyytiä P, Bäckström P, Liljequist S (1999) Site-specific NMDA receptor antagonists produce differential effects on cocaine self-administration in rats. Eur J Pharmacol 378:9-16
15. Jun JH, Schindler CW (2000) Dextromethorphan alters methamphetamine self-administration in the rat. Pharmacol Biochem Behav 67:405-409
16. Karler R, Calder LD (1992) Excitatory amino acids and the actions of cocaine. Brain Res 582:143-146
17. Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56
18. Kemp JA, Leeson PD (1993) The glycine site of the NMDA receptor - five years on. Trends Pharmacol Sci 14:20-25
19. Khan MA, Shoaib M (1996) Neuroanatomical localization of the effects of (+)-HA966 on locomotor activity after cocaine injections to the nucleus accumbens of rats. Brain Res 719:198-202
20. Koob GF (1992) Neural mechanisms of drug reinforcement Ann N Y Acad Sci 654:171-191
21. Kretschmer BD (1998) Ligands of the NMDA receptor-associated glycine recognition site and motor behavior. Amino Acids 14:227-234
22. LeSage MG, Stafford D, Glowa JR (1999) Preclinical research on cocaine self-administration: environmental determinants and their interaction with pharmacological treatment Neurosci Biobehav Rev 23:717-741
23. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424
24. Morrow BA, Taylor JR, Roth RH (1995) R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures. Brain Res 673:165-169
25. Morrow BA, Elsworth JD, Zito C, Roth RH (1999) Biochemical and behavioral anxiolytic-like effects of R(+)HA-966 at the level of the ventral tegmental area in rats. Psychopharmacology 143:227-234
26. 1B receptor stimulation enhances cocaine reinforcement. J Neurosci 18:10078-10089
27. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York
28. Pierce RC, Meil WM, Kalivas PW (1997) The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology 133:188-195
29. Pulvirenti L, Balducci C, Koob GF (1997) Dextromethorphan reduces intravenous cocaine self-administration in the rat. Eur J Pharmacol 321:279-283
30. Ranaldi R, French E, Roberts DC (1996) Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats. Psychopharmacology 128:83-88
31. Ritz MC, Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010-1017
32. Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46:635-645
33. Roberts DC (1992) Neural substrates mediating cocaine reinforcement: the role of monoamine systems. In: Lakoski JM, Galloway MP, White FJ (ed) Cocaine: pharmacology, physiology and clinical strategies. CRC Press, Boca Raton, pp 73-90
34. Roberts DC, Koob GF (1982) Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 17:901-904
35. Roberts DC, Zito KA (1987) Interpretation of lesion effects on stimulant self-administration. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, Berlin Heidelberg, New York, pp 87-103
36. Roberts DC, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615-620
37. Rockhold RW (1998) Glutamatergic involvement in psychomotor stimulant action. Prog Drug Res 50:155-192
38. Ross SB, Renyi AL (1967) Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur J Pharmacol 2:181-186
39. Ross SB, Renyi AL (1969) Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur J Pharmacol 7:270-277
40. Shoaib M, Shippenberg TS, Goldberg SR, Schindler CW (1995) Behavioral studies with the glycine partial agonist (+)-HA966 on cocaine-induced locomotor activity and reinforcement. Behav Pharmacol 6:568-576
41. Singh L, Donald AE, Foster AC, Hutson PH, Iversen LL, Iversen SD, Kemp JA, Leeson PD, Marshall GR, Oles RJ et al. (1990a) Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. Proc Natl Acad Sci USA 87:347-351
42. Singh L, Menzies R, Tricklebank MD (1990b) The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/ N-methyl-D-aspartate receptor. Eur J Pharmacol 186:129-132
43. Stafford D, LeSage MG, Glowa JR (1998) Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review. Psychopharmacology 139:169-184
44. Taylor D, Ho BT (1978) Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res Commun Chem Pathol Pharmacol 21:67-75
45. Tortella FC, Pellicano M, Bowery NG (1989) Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci 10:501-507
46. Wilson MC, Schuster CR (1973) The effects of stimulants and depressants on cocaine self-administration behavior in the rhesus monkey. Psychopharmacologia 31:291-304
47. Witkin JM, Brave S, French D, Geter-Douglass B (1995) Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl7-D-aspartate receptor. J Pharmacol Exp Ther 275:1267-1273
48. Wong CS, Cherng CH, Luk HN, Ho ST, Tung CS (1996) Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Eur J Pharmacol 297:27-33
49. Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200
50. Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187:547-549
51. Yokel RA, Wise RA (1976) Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology 48:311-318